Crohn's disease Trials in Tromsø, Norway
Conditions / Crohn's disease / Tromsø, Norway
Clinical trials for Crohn's disease investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00160706 | A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease | COMPLETED | PHASE3 |
| NCT01277666 | A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease | COMPLETED | PHASE3 |
| NCT00308581 | Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab | COMPLETED | PHASE3 |
| NCT04844606 | A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) | RECRUITING | — |
| NCT05242471 | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02148640 | The NOR-SWITCH Study | COMPLETED | PHASE4 |
| NCT00160524 | A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] | COMPLETED | PHASE3 |
| NCT05509777 | A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease | RECRUITING | PHASE3 |
| NCT05923073 | A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease | RECRUITING | PHASE3 |
| NCT01316939 | GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease | TERMINATED | PHASE3 |